SUDOSCAN at the 18th European Congress of Clinical Neurophysiology 2023
Sudoscan au congrès SFD de Montpellier du 21 au 24 mars 2023
Sudoscan and Cardiovascular outcomes in Hemodialysis
Sudoscan à la 27ème édition des Journées de la Société Francophone du Nerf Périphérique
Webinar: Early detection of Peripheral Neuropathy in Prediabetes and Diabetes to improve patient management – March 17th 2023
SUDOSCAN at the 58th National Neurology Congress 2022
About Sudoscan
Impeto Medical is a medical device company part of WITHINGS company. Created in June 2005, its corporate headquarters are located close to Paris, France; the company is also present in San Diego, CA, USA.
COPYRIGHT 2005-2024 – IMPETO MEDICAL © All rights reserved.
More information
Contact info
Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
